Greece proposes €1.4 billion National Cancer Fund for better care

Greek health economists advocate for a €1.4 billion National Cancer Fund to enhance oncology care, utilizing existing revenues like excise duties. The current cost of cancer management in Greece is approximately €1.35 billion, which constitutes about 8% of the total health expenditure, slightly below the EU average of 9% to 9.5%. The proposal emphasizes the need for public funding to address inequalities in cancer care, highlighting the importance of a national cancer registry and a comprehensive strategy for effective implementation. The concept of 'health taxes' has emerged as a potential funding source, targeting products detrimental to health, such as tobacco and sugary beverages. This approach aims to reduce consumption of harmful products while generating revenue that can be earmarked for health system support. Kostas Athanasakis, a health economist, stresses that combining taxation with subsidies for beneficial products is crucial for the success of this funding model. George Kapetanakis, President of the Hellenic Cancer Federation, underscores the necessity of strategic planning to improve interconnection in cancer care, ensuring that patient experiences and needs are prioritized. He advocates for a holistic approach that encompasses prevention, treatment, and palliative care, emphasizing the complexity of cancer management and the need for coordinated efforts. Industry stakeholders, including Bristol Myers Squibb Greece, have also highlighted the urgency of developing a National Strategic Plan for Cancer. They support the establishment of a National Cancer Fund, which would facilitate comprehensive care across all stages of cancer, ultimately aiming to enhance the quality of life for patients in Greece.